Name: HALEON PLC (H6D0) Stock
Brand: HALEON PLC
Rating: 4.5 (3 reviews)

Question 1

Can you describe the business of HALEON PLC?

Accepted Answer

Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Question 2

What is the stock price of HALEON PLC today?

Accepted Answer

The current stock price of H6D0.DE is 4.064 EUR. The price increased by 0.87% in the last trading session.

Question 3

Does HALEON PLC pay dividends?

Accepted Answer

HALEON PLC (H6D0.DE) has a dividend yield of 1.94%. The yearly dividend amount is currently 0.07.

Question 4

What is the ChartMill technical and fundamental rating of H6D0 stock?

Accepted Answer

H6D0.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

HALEON PLC (H6D0.DE) Stock Price, Forecast & Analysis

H6D0.DE Latest News, Press Relases and Analysis